News by Maddyness
4 May 2020
4 May 2020
Temps de lecture : 2 minutes
2 min
0

Biotech Lifebit raises £6M Series A investment

Lifebit, a leading innovator in bioinformatics and cognitive software solutions, received a £6M Series A investment from Idinvest Partners, Pentech Ventures LLP, Beacon Capital and Connect Ventures. Lifebit aims to truly democratise access to genomics data by enabling researchers to become experts at running complex analyses and to unlock the value of this data.
Temps de lecture : 2 minutes

Lifebit CloudOS is becoming the industry’s standard for unified and secure research over distributed big data. With this investment, the company will be able to fuel ongoing product innovations and global market expansion.

On top of its core foundation, the platform provides integration to all open-source analysis and visualisation tools, as well as a marketplace of proprietary ones, a powerful data and cohort browser, and advanced AI functionality that together are powering discoveries in drugs and personalised medicine.

“We are incredibly proud of the validation and confidence demonstrated by all of our investors, especially considering the current economic uncertainty due to the Covid-19 pandemic. We are also thrilled to welcome Idinvest to the Lifebit family, who brings to us a wealth of expertise in the area of high growth biotech companies. This financing comes at a pivotal time as we are rapidly expanding our global presence, accelerating product innovation and continuing to grow our team of world-class engineers and bioinformaticians. With our partners and customers, we are pushing forward the frontiers of health and creating a more integrated, accessible landscape of knowledge that enriches life and enables meaningful breakthroughs.” - Dr Maria Chatzou Dunford, CEO of Lifebit

Lifebit CloudOS is being deployed by leading life sciences organisations to advance research and find cures. Its best-in-class user experience is removing barriers and proving real transformation for Lifebit clients, including top-tier pharmaceutical organisations, as it allows all researchers, from novice to expert, to perform groundbreaking research.

“Lifebit is uniquely positioned in the marketplace. Their product delivers a radically new approach to bioinformatics. We are very impressed with the innovation and commercialisation Lifebit has accomplished - this leading team of scientists, engineers, and entrepreneurs are making omics data analysis accessible, secured and collaborative for labs everywhere. We are delighted to lead this financing to help open the next chapter in Lifebit’s exciting growth story.” - Antoine Zins, Investment Manager at Idinvest

Lifebit CloudOS 2.0 integrates the Biobank Data Browser engineered for the extreme scale and complexities of biobank big data. Already deployed by Lifebit enterprise clients, the biobank browser allows users to access and utilise the extensive knowledge bases generated by biobanks, which are amassing mountains of genomic and clinical data derived from hundreds of thousands of volunteer participants.

Partager
Don't let the next economy pass you by, get the latest news with the Maddyness newsletter at 8h15.